1q21 amplification with additional genetic abnormalities but not isolated 1q21 gain is a negative prognostic factor in newly diagnosed patients with multiple myeloma treated with thalidomide-based regimens.
作者信息
Grzasko Norbert, Hus Marek, Chocholska Sylwia, Pluta Andrzej, Hajek Roman, Dmoszynska Anna
出版信息
Leuk Lymphoma. 2012 Dec;53(12):2500-3. doi: 10.3109/10428194.2012.684349. Epub 2012 May 22.
PMID:22497640
Abstract
摘要
Zotero 插件